IRCT201301053930N17CompletedPhase 3
Aripiprazole versus risperidone in the treatment of children and adolescents with tic disorders, a double blind randomized controlled clinical trial
Vice chancellor for research, Shiraz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 5 years to 19 years (—)
- Sex
- All
Inclusion Criteria
- •children and adolescents aged 6 to 18 years; total score of YGTS more than 21. Exclusion criteria: Marked general medical condition; hypersensitivity to the medications.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 3
Aripiprazole versus risperidone for treatment of autismPervasive developmental disorders.Childhood autismIRCT201110233930N15Vice chancellor for research, Shiraz University of Medical Sciences50
Completed
Phase 2
The Comparison of Aripiprazole versus Risperidone in Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder.Hyperkinetic disordersIRCT2013050413215N1Vice Chancellor for Research, Shahid Beheshti University of Medical Sciences40
Recruiting
Phase 3
Aripiprazle in ADHD and ODDIRCT20160530028182N5Sanandaj University of Medical Sciences60
Completed
Phase 2
aripiprazole versus risperidone for treating schizophreniaschizophrenia.SchizophreniaIRCT201305233930N26Shiraz University of Medical sciences60
Recruiting
Phase 3
Treating obsessive-compulsive disorder in patients with Bipolar disorderCondition 1: Bipolar disorder. Condition 2: Obsessive-Compulsive disorder.Obsessive-compulsive disorderBipolar disorderIRCT20200614047761N1Babol University of Medical Sciences60